Delivery Order SPE2DB24D1021-SPE2DB25FEZWC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Onfil 10 mg tablets (100-count) under a firm fixed-price contract with a ceiling value of $7,471.73. This non-set-aside award is classified as a delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a specific pharmaceutical supply requirement within the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Onfil 10 mg tablets (100 count) with a ceiling value of $3,064.78. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Onfil 10 mg tablets (100-count units) valued at $11,683.85 under a firm fixed-price contract type. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office...
- The Defense Logistics Agency awarded a $4,906.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for 100 tablets of Onfil 10 mg. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,422.19 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded contract utilizes firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA 19428....
- The Defense Logistics Agency awarded a delivery order valued at $3,589.68 to AmerisourceBergen Drug Corp for Onfil 10 mg tablets (100 count) on July 10, 2025, with completion expected by July 11, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX, valued at $999,999,999.00 through December 2026). The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfil 20 mg with a ceiling value of $11,018.34. This firm fixed-price, competitively awarded delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA, leveraging the company's established capabilities as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,011.68 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on September 3, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $11,112.74 to AmerisourceBergen Drug Corp for the supply of Onfil 20 mg tablets in quantities of 100 units. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive set-aside. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,130.37 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements....
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZWCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Onfil 10 mg tablets (100-count units) with a ceiling value of $4,414.14. This competitive, non-set-aside award reflects a firm fixed-price delivery order placed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply chain operations, consistent with AmerisourceBergen's role as a critical vendor for military and veteran healthcare systems. The company's comprehensive IDC with DLA enables it to fulfill a broad spectrum of pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to meet federal procurement requirements through competitive open-market awards, delivering both brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/19/25 |